U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07853716) titled 'REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care' on Sept. 17.
Brief Summary: REFINE-CAC is a prospective, multi-center trial assessing the management of asymptomatic participants with CAC scores 1-299 Agatston units or incidental CAC findings on chest computed tomography (CT), all of whom will undergo CCTA and are blinded to the coronary anatomy (e.g., % stenosis). The trial includes a randomized, controlled pathway and a single arm, observational registry pathway.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
CAD - Coron...